Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)

Name

Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)

Legal name

Deutsches Zentrum für Neurodegenerative Erkrankungen e. V.

Website

https://dzne.de

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Bonn

HQ country

Germany

HQ region

Europe

Offices11 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Distribution channels3 records

Marketing channels9 records

Core offering

DZNE is a publicly funded translational neuroscience research institute that conducts fundamental, clinical, population, systems medicine, and health care research on neurodegenerative diseases (Alzheimer's, Parkinson's, ALS, FTD, Huntington's, Lewy-body dementia, ataxias, and childhood dementia). It provides shared scientific infrastructure — including Brain Bank, Human Imaging, Biorepository, FLOCUS flow cytometry, and Swarm Learning Hub federated AI — and runs clinical trials and population studies (e.g., the Rhineland Study) accessible to academic and industry collaborators and study participants.

Product overview

DZNE operates as a neurodegenerative disease research center with a translational research strategy connecting fundamental research, clinical research, population studies, systems medicine, and health care research. The organization provides a portfolio of specialized research infrastructure services including FLOCUS (flow cytometry and cell sorting), Biorepository (biological sample storage), Brain Bank (post-mortem tissue), Human Imaging (MRI and specialized scanning), and Swarm Learning Hub (federated AI learning). DZNE also offers DECLARE (clinical research e-learning platform) and Clinical Databases with audit trail capabilities for clinical trial data management. Research areas span Alzheimer's, Parkinson's, ALS, Lewy-Body Dementia, Frontotemporal Dementia, Huntington's, Ataxia, and Childhood Dementia.

Differentiator

Problem solved

Functional benefit

Brands

• Noten und Neuronen: A podcast series featuring music and brain research, bringing neuroscience to audiences through concerts and discussions.
• 90 Milliarden

Products and services

• FLOCUS Flow cytometry and cell sorting scientific service providing analysis and sorting capabilities for scientific research groups, part of DZNE's scientific service offerings.
• Biorepository Biological sample storage and management service for research purposes, providing standardized sample handling and storage infrastructure across DZNE sites.
• Swarm Learning Hub Federated learning platform enabling collaborative AI research across institutions without sharing raw data, supporting privacy-preserving machine learning across distributed research networks.
• Brain Bank Repository of post-mortem brain tissue for neurodegenerative disease research, providing standardized samples for fundamental and clinical research.
• Human Imaging Advanced brain imaging capabilities including MRI and specialized scanning technologies (including 7-Tesla) for studying neurodegenerative diseases in living subjects.
• DECLARE E-Learning platform for clinical research training, providing educational content and training verification for clinical research personnel.
• Clinical Databases Clinical research databases with audit trail capabilities for tracking data entry and modifications in clinical studies, supporting compliance with regulatory requirements.

Quantifiable outcome

• Researchers at DZNE and Ulm University Hospital identified five specific subgroups of excitatory neurons most vulnerable to TDP-43 pathology in ALS, providing a cell-by-cell map of disease progression for more precise therapeutic development.
• +2 more outcomes

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Ten partnerships are on record, tiered core, flagship and minor.

• Ludwig-Maximilians-Universität München (LMU)coreStrategic or Co-development PartnerDZNE scientists and LMU Munich researchers collaborate on neurodegeneration research. Notable joint work includes the discovery that loss of smell precedes cognitive decline in Alzheimer's disease, published in Nature Communications.
• Ulm University HospitalcoreStrategic or Co-development PartnerDZNE and Ulm University Hospital collaborated on a study published in Nature Communications identifying five specific subgroups of excitatory neurons vulnerable to TDP-43 pathology in ALS and ALS-FTD cases, analyzing post-mortem tissue from approximately 80 individuals across four countries.
• CURE-ND (European Alliance for Neurodegeneration)flagshipStrategic or Co-development PartnerCURE-ND is a European alliance led by DZNE to accelerate neurodegeneration research. The alliance published a position paper in The Lancet Neurology calling for faster progress in neurodegenerative disease research. DZNE serves as a central coordinating institution for this pan-European initiative.
• Longitude Prize on ALS Consortium (Europe, North America, Asia)flagshipStrategic or Co-development PartnerDZNE leads an international consortium selected for the Longitude Prize on ALS, bringing together leading institutions from Europe, North America, and Asia to apply artificial intelligence to one of the most complex challenges in neurology.
• Swarm Learning Hub PartnerscoreTechnology or IntegrationDZNE's Swarm Learning Hub enables collaborative, privacy-preserving AI research across multiple partner institutions by sharing model parameters rather than raw data. This platform supports decentralized machine learning across the DZNE network and external collaborators.
• Helmholtz AssociationcoreStrategic or Co-development PartnerDZNE is part of the Helmholtz Association, Germany's largest scientific organization. This partnership provides long-term, publicly funded research infrastructure, strategic research priorities, and integration into Germany's premier health research ecosystem.
• Deutsche Zentren der Gesundheitsforschung (DZG)coreStrategic or Co-development PartnerDZNE is a member of the German Centers for Health Research (DZG), a network of German health research centers addressing major diseases. DZNE participated in the 1st DZG Day Lower Saxony in Hannover in April 2026.
• Neuronal Networks Project ConsortiumcoreStrategic or Co-development PartnerDZNE leads the Neuronal Networks project, a research platform bringing together DZNE research groups across its sites to advance understanding of neuronal networks in neurodegeneration.
• SCAIFIELD Project ConsortiumminorStrategic or Co-development PartnerDZNE participates in the SCAIFIELD project, a collaborative research initiative focused on spinocerebellar ataxias, involving a multi-institutional consortium with patient information components.
• Universities, Research Institutions, Clinics, and Pharmaceutical IndustrycoreStrategic or Co-development PartnerDZNE's translational research strategy involves continuous exchange and collaboration with partners from universities, other research institutions, hospitals/clinics, and the pharmaceutical industry, to accelerate the transfer of scientific results into clinical application.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Karolinska Institutet: Swedish medical university with major neurodegeneration research programs including the Karolinska Neurodegeneration Center. Comparable as a publicly funded European research and clinical translation hub.
• National Institute on Aging (NIH/NIA): US federal institute leading Alzheimer's and related dementias research, including ADNI and major clinical trial infrastructure. Comparable in translational scope, scale, and public funding model.
• Max Planck Institute for Biology of Ageing–Demography: German Max Planck research institute focused on ageing biology with neurodegeneration relevance. Comparable as a publicly funded German basic-research counterpart, though broader in age-related biology.

Direct peers

• Francis Crick Institute: UK biomedical research institute with translational neuroscience programs. Comparable as a publicly funded, multi-disciplinary research institute with significant neurodegeneration research and similar scale (1,000+ scientists).
• Allen Institute for Brain Science: US nonprofit research organization conducting large-scale neuroscience research including brain mapping and cell atlases. Directly comparable in mission and translational scope, particularly through shared projects like the BRAIN Initiative cell census work.
• UK Dementia Research Institute (UK DRI): UK's national institute dedicated to dementia and neurodegeneration research, funded by the MRC, Alzheimer's Society, and Alzheimer's Research UK. Directly comparable as a multi-site, publicly funded translational neuroscience institute with similar focus on dementia mechanisms and therapy development.
• Salk Institute for Biological Studies: US nonprofit basic research institute with major neurodegeneration and aging research programs. Comparable in scale, nonprofit research model, and emphasis on fundamental neuroscience with translational potential.
• Janelia Research Campus (HHMI): HHMI's research campus focused on neuroscience and imaging tool development. Comparable in scale, technology focus (advanced imaging, AI/ML), and translational neuroscience emphasis.
• German Cancer Research Center (DKFZ): DZNE's sister Helmholtz Association center focused on oncology. Closely comparable organizational model, funding structure, scale, and translational research approach — provides the best benchmark for DZNE's institutional scale and budget.
• Champalimaud Foundation: Portuguese research and clinical institution focused on neuroscience and oncology. Comparable as a European translational research institution with major neurodegeneration programs and clinical infrastructure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/dzne_de
• YouTubeyoutube.com/channel/dzne
• Facebookfacebook.com/dzne.de
• LinkedInlinkedin.com/company/dzne
• Instagraminstagram.com/dzne_de

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)